Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Acta Psychiatrica Scandinavica

• Publication date

  1991-04-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1111/j.1600-0447.1991.tb05539.xPMID 1709331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Arginine vasopressin, but not corticotropin releasing factor, is a potent stimulator of adrenocorticotropic hormone following electroconvulsive treatment

  2005cited by this paper
• Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics

  2005cited by this paper
• Neuropeptides in the human appendix

  1989cited by this paper
• Reduced CSF neurotensin concentration in drug-free schizophrenic patients.

  1988cited by this paper
• Neuropeptides, Dopamine, and Schizophrenia a

  1988cited by this paper
• Neurotransmitters, receptors and neuropeptides in post‐mortem brains of chronic schizophrenic patients

  1988cited by this paper
• Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively.

  1988cited by this paper
• Post-mortem Study of Chronic Schizophrenic Brains

  1987cited by this paper
• Dopamine receptor asymmetry in schizophrenia.

  1987cited by this paper
• Is there gliosis in schizophrenia? Investigation of the temporal lobe.

  1987cited by this paper
• Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patients.

  1987cited by this paper
• Peptide YY-like immunoreactivity in the central nervous system of the rat.

  1986cited by this paper
• Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatric disorders.

  1986cited by this paper
• Delta-sleep inducing peptide in cerebrospinal fluid from schizophrenics, depressives and healthy volunteers.

  1985cited by this paper
• CSF-Neuropeptides in schizophrenia

  1985cited by this paper
• Radioimmunoassay of delta sleep-inducing peptide using an iodinated p-hydroxyphenylpropionic acid derivative as tracer.

  1983cited by this paper
• Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia

  1983cited by this paper
• Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment.

  1982cited by this paper
• SUBNORMAL CSF LEVELS OF NEUROTENSIN IN A SUBGROUP OF SCHIZOPHRENICS AND NORMALIZATION AFTER NEUROLEPTIC TREATMENT

  1982cited by this paper
• Endorphins and Opiate Antagonists in Psychiatric Research

  1982cited by this paper
• Hormones, dopamine receptors and schizophrenia.

  1981cited by this paper
• Brain tryptophan metabolism in schizophrenia: A post mortem study of metabolites on the serotonin and kynurenine pathways in schizophrenic and control subjects

  1979cited by this paper
• Monoamines and monoamine metabolites in brains from demented schizophrenics

  1979cited by this paper
• Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical Findings

  1979cited by this paper
• Endorphins in human cerebrospinal fluid: Clinical correlations to some psychotic states

  1978cited by this paper
• Norepinephrine in chronic paranoid schizophrenia: above-normal levels in limbic forebrain.

  1978cited by this paper
• Increased dopamine-receptor sensitivity in schizophrenia.

  1978cited by this paper
• Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses.

  1977cited by this paper
• Increased CSF levels of endorphines in chronic psychosis.

  1976cited by this paper

• Investigation of serum galanin, alarin, meteorin-like protein, and ischemia modified albumin levels in patients with schizophrenia

  2024cites this paper
• Cross talk about the role of Neuropeptide Y in CNS disorders and diseases.

  2023cites this paper
• Multiple Aspects of Inappropriate Action of Renin–Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases

  2022cites this paper
• Mechanistic insights into the protective role of eugenol against stress-induced reproductive dysfunction in female rat model.

  2022cites this paper
• The implications of hypothalamic abnormalities for schizophrenia.

  2021cites this paper
• Association Between Polymorphisms in the 5′ Region of the GALR1 Gene and Schizophrenia in the Northern Chinese Han Population: A Case–Control Study

  2020cites this paper
• NDT_A_256644 1519..1532

  2020cites this paper
• Expression of vasopressin mRNA in the hypothalamus of individuals with a diagnosis of schizophrenia

  2019cites this paper
• The hypothalamus and neuropsychiatric disorders: psychiatry meets microscopy

  2018cites this paper
• Crossing the Worm-Brain Barrier by Using Caenorhabditis elegans to Explore Fundamentals of Human Psychiatric Illness

  2018cites this paper
• Transcriptional regulation of corticotropin-releasing hormone gene in stress response

  2018cites this paper
• Effects of Gladiolus dalenii on the Stress-Induced Behavioral, Neurochemical, and Reproductive Changes in Rats

  2017cites this paper
• Mapping the effects of vitamin D in multiple sclerosis : a 3D perspective

  2017cites this paper
• Chapter 23 – Modeling Schizophrenia in Animals

  2017cites this paper
• Insulin-regulated aminopeptidase immunoreactivity is abundantly present in human hypothalamus and posterior pituitary gland, with reduced expression in paraventricular and suprachiasmatic neurons in chronic schizophrenia

  2017cites this paper
• Network of nuclear receptor ligands in multiple sclerosis: Common pathways and interactions of sex-steroids, corticosteroids and vitamin D3-derived molecules.

  2016cites this paper
• Possible contribution of epigenetic changes in the development of schizophrenia-like behavior in vasopressin-deficient Brattleboro rats.

  2016cites this paper
• The prepulse inhibition deficit appearance is largely independent on the circadian cycle, body weight, and the gender of vasopressin deficient Brattleboro rat

  2016cites this paper
• Social feeding in Caenorhabditis elegans is modulated by antipsychotic drugs and calmodulin and may serve as a protophenotype for asociality.

  2015cites this paper
• Einfluss von Neuropeptid Y-Genvarianten auf die antipsychotika- induzierte Gewichtszunahme bei Patienten mit Schizophrenie

  2015cites this paper
• Effect of Maternal Deprivation on Brain and Behaviors in Experimental Models

  2014cites this paper
• Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders.

  2014cites this paper
• Humans and great apes share increased neocortical neuropeptide Y innervation compared to other haplorhine primates

  2014cites this paper
• Differential impact of GAD67 suppression in distinct GABA-ergic interneuron populations: Implications for mental illness

  2014cites this paper
• Neuropeptide systems and schizophrenia.

  2013cites this paper
• Multiple Origins of Sex Differences in Brain

  2013cites this paper
• Classical Neurotransmitters and Neuropeptides Involved in Schizophrenia: How to Choose the Appropriate Antipsychotic Drug?

  2013influential citation
• Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis

  2013cites this paper
• Chapter 30 – Modeling Schizophrenia in Animals

  2013cites this paper
• Gedächtnisleistung und Schizophrenie in Assoziation mit einem Polymorphismus des Neuropeptid Y-Gens

  2013cites this paper
• Sex Differences in HPA and HPG Axes Dysregulation in Major Depressive Disorder: The Role of Shared Brain Circuitry Between Hormones and Mood

  2013cites this paper
• Endocrine adaptation to repeated psychological stress in the adult male rat depends on central activation of vasopressin V1a receptors

  2012cites this paper
• Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response.

  2012cites this paper
• A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia.

  2012cites this paper
• EFFECTS OF METHAMPHETAMINE ON STRIATAL NEUROPEPTIDE Y FUNCTION

  2012cites this paper
• Genetic Association of NPY Gene Polymorphisms with Dampness-Phlegm Pattern in Korean Stroke Patients

  2011cites this paper
• O sistema hipocampo-córtex retrosplénico na epilepsia experimental: estudos morfológico e comportamental

  2011cites this paper
• Novel animal models for studying complex brain disorders: BAC-driven miRNA-mediated in vivo silencing of gene expression

  2010cites this paper
• Sex Differences in Corticotropin-Releasing Factor Receptor Signaling and Trafficking: Potential Role in Female Vulnerability to Stress-Related Psychopathology

  2010cites this paper
• How stress affects female reproduction: An overview

  2009cites this paper
• Schizophrenia pathophysiology: are we any closer to a complete model?

  2009cites this paper
• No association between a functional polymorphism in the promoter region of the neuropeptide Y gene (-485C>T) and schizophrenia.

  2009cites this paper
• Neuropeptides involved in the pathophysiology of schizophrenia and major depression

  2009cites this paper
• Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence

  2009cites this paper
• Gene Expression Changes and Potential Impact of Endophenotypes in Major Psychiatric Disorders

  2009cites this paper
• Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays

  2008cites this paper
• The Neuroimmune System in Psychiatric Disorders

  2008cites this paper
• Blood and Brain Gene Expression in Major Psychiatric Disorders: A Search for Biomarkers

  2008cites this paper
• A resistance gene in disguise for schizophrenia?

  2007cites this paper
• Behavioral profiling of NPY in aggression and neuropsychiatric diseases.

  2007cites this paper
• Relevance of neuropeptide Y (NPY) in psychiatry.

  2007cites this paper
• Involvement of neuropeptide systems in schizophrenia: human studies.

  2007cites this paper
• Neuropeptide Y mRNA expression levels following chronic olanzapine, clozapine and haloperidol administration in rats.

  2006cites this paper
• Reduced density of neuropeptide Y neurons in the somatosensory cortex of old male and female rats: relation to cholinergic depletion and recovery after nerve growth factor treatment.

  2006cites this paper
• Absence of a Difference in the Neurosecretory Activity of Supraoptic Nucleus Vasopressin Neurons of Neuroleptic-Treated Schizophrenic Patients

  2006cites this paper
• CHAPTER 48 – Stress and the Reproductive System

  2006cites this paper
• Male patients with paranoid schizophrenia have greater ACTH and cortisol secretion in response to metoclopramide-induced AVP release.

  2005cites this paper
• Social Interaction Deficits Caused by Chronic Phencyclidine Administration are Reversed by Oxytocin

  2005cites this paper
• Discovering the Genetics of Complex Disorders Through Integration of Genomic Mapping and Transcriptional Profiling

  2005cites this paper
• The central vasopressinergic system: examining the opportunities for psychiatric drug development.

  2005cites this paper
• Early maternal deprivation retards neurodevelopment in Wistar rats

  2005cites this paper
• A family-based association study of schizophrenia with polymorphisms at three candidate genes.

  2005cites this paper
• The stress system in the human brain in depression and neurodegeneration.

  2005cites this paper
• Does neuropeptide Y (NPY) mediate the effects of psychotropic drugs?

  2004cites this paper
• Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree.

  2004cites this paper
• The "Yoking" of glutamatergic brain mechanisms involved in controlling brain neuronal excitability and psychosis to brain mechanisms involved in appetite regulation: a new hypothesis on the origin of psychosis.

  2004cites this paper
• Corticotropin-Releasing Factor Receptors CRF1 and CRF2 Exert Both Additive and Opposing Influences on Defensive Startle Behavior

  2004cites this paper
• Early maternal deprivation as an animal model for schizophrenia.

  2003cites this paper
• Subchronic phencyclidine administration alters central vasopressin receptor binding and social interaction in the rat.

  2003cites this paper
• Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans.

  2003cites this paper
• Early maternal deprivation alters hippocampal levels of neuropeptide Y and calcitonin-gene related peptide in adult rats.

  2002cites this paper
• Long-lasting effects of prenatal MAM treatment on water maze performance in rats: associations with altered brain development and neurotrophin levels.

  2002cites this paper
• The Effect of Exercise on the Hypothalamo—Pituitary—Adrenal Axis

  2000cites this paper
• Galanin receptors and their therapeutic potential

  2000cites this paper
• Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y(1) receptor antagonist BIBO 3304.

  2000cites this paper
• Effects of typical and atypical antipsychotics on neuropeptide Y in rat brain tissue and microdialysates from ventral striatum

  2000cites this paper
• Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder.

  1999cites this paper
• Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat.

  1999cites this paper
• Sex hormones and glucocorticoids: interactions with the immune system.

  1999cites this paper
• Sex Hormones and Glucocorticoids: Interactions with the Immune System

  1999cites this paper
• Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems.

  1999cites this paper
• Effects of Stimulants of Abuse on Extrapyramidal and Limbic Neuropeptide Y Systems 1

  1999cites this paper
• Cholinergic muscarinic mechanisms regulate neuropeptide Y gene expression via protein kinase C in human neuroblastoma cells.

  1998cites this paper
• Relationships between CSF neuropeptides and temperament traits in suicide attempters

  1998cites this paper
• The human hypothalamo-neurohypophysial system in health and disease.

  1998cites this paper
• The therapeutic potential of neuropeptide Y in central nervous system disorders with special reference to pain and sympathetically maintained pain.

  1997cites this paper
• A Neuroimmunological Model of Schizophrenia and Major Depression: A Review

  1997cites this paper
• Sexual dimorphism of the human stress response may be due to estradiol-mediated stimulation of hypothalamic corticotropin-releasing hormone synthesis.

  1997cites this paper
• Effects of foetal ethanol exposure on hypothalamic-pituitary adrenal axis function and behaviour on the elevated plus maze

  1997cites this paper
• General Adaptation Syndrome

  1997cites this paper
• Phencyclidine alters regional concentrations of neuropeptide Y and peptide YY in rat brain.

  1996cites this paper
• The Therapeutic Potential of Neuropeptide Y

  1996cites this paper
• Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex.

  1996cites this paper
• ORIGINAL ARTICLES i Neuropeptide Deficits in Schizophrenia Alzheimer's Disease Cerebral Cortex

  1996cites this paper
• Comparison of neurotrophin regulation of human and rat neuropeptide Y (NPY) neurons: induction of NPY production in aggregate cultures derived from rat but not from human fetal brains.

  1996cites this paper
• Human fetal brain cells in aggregate culture: A model system to study regulatory processes of the developing human neuropeptide Y (NPY)-producing neuron

  1996cites this paper
• The three-way interactions between the hypothalamic-pituitary-adrenal and gonadal axes and the immune system.

  1996cites this paper
• Sexual dimorphism of stress response and immune/ inflammatory reaction: the corticotropin releasing hormone perspective

  1995cites this paper
• Increases in cortical neuropeptide Y and somatostatin concentrations following haloperidol-depot treatment in rats.

  1995cites this paper
• Neurobiology and clinical aspects of neuropeptide Y.

  1995cites this paper